720
Participants
Start Date
January 9, 2017
Primary Completion Date
March 31, 2021
Study Completion Date
March 31, 2021
Migraine Prophylactic Therapy Only
Start of new migraine preventive therapy or adjustment of current preventive therapy without immediate discontinuation of the overused medication(s)
Discontinuation of Overused Medication
Immediate discontinuation of the overused medication(s) and the start of new migraine preventive therapy or adjustment of current preventive therapy
Preferred Headache Center, Pittsburgh
Thomas Jefferson University Hospital Headache Center, Philadelphia
West Virginia University Neurology, Morgantown
Memorial Healthcare, Hollywood
University of Miami Miller School of Medicine, Miami
The Headache Center, Ridgeland
Norton Neurology, Louisville
Toledo Clinic Adult Neurology, Toledo
Cleveland Clinic, Cleveland
University of Cincinnati Neurology, Cincinnati
University of Cincinnati Headache Center, Dayton
Henry Ford Allegiance Health, Jackson
Mayo Clinic Headache Center, Rochester
Clinvest Research, Springfield
University of Colorado Denver Headache Center, Aurora
Blue Sky Neurology, Greenwood Village
University of Colorado Denver Primary Center, Denver
University of Utah Primary Care, Salt Lake City
University of Utah General Neurology, Salt Lake City
University of Utah Headache Center, Salt Lake City
Mayo Clinic in Arizona Headache Center, Phoenix
Mayo Clinic in Arizona Neurology Center, Phoenix
Honor Health Neurology, Scottsdale
Mayo Clinic Thunderbird, Scottsdale
Northern Arizona Healthcare Medical Group, Flagstaff
Keck Medical Center of USC, Los Angeles
University of Washington, Seattle
Brigham Women's Hospital Headache Clinic, Boston
Brigham Women's Hospital Neurology Clinic, Boston
Lead Sponsor
Patient-Centered Outcomes Research Institute
OTHER
Mayo Clinic
OTHER